Literature DB >> 16856227

The obstetrician's view: ethical and societal implications of non-invasive prenatal diagnosis.

Richard P Smith1, Hennie Lombaard, Peter W Soothill.   

Abstract

We believe non-invasive prenatal diagnosis is about to have a massive impact on the way fetal medicine is practised. There will be many great advantages and improvements, but the technology also has the potential to be used for non-medical reasons such as sex selection and paternity testing. We discuss some of the issues that may face obstetricians in the future as a result of this emerging technology. Copyright 2006 John Wiley & Sons, Ltd.

Mesh：

Substances：

Year:  2006        PMID： 16856227     DOI： 10.1002/pd.1476

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN： 0197-3851            Impact factor:   3.050


  5 in total

1.  Non-invasive prenatal testing: ethical issues explored.

Authors:  Antina de Jong; Wybo J Dondorp; Christine E M de Die-Smulders; Suzanne G M Frints; Guido M W R de Wert
Journal:  Eur J Hum Genet       Date:  2009-12-02       Impact factor: 4.246

2.  Is there a Role for Genetic Counselors in Prenatal Paternity Testing? - an Assessment Based on Audit of 13 years of Clinical Experience in South Australia.

Authors:  Kate E Riley; Hayley Salvemini; Eric Haan; Lara Fitzgerald; Kirsty Stallard; Sarah Borrie; Electra Pontikinas; Anne Baxendale
Journal:  J Genet Couns       Date:  2016-07-21       Impact factor: 2.537

3.  Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation.

Authors:  Lauren C Sayres; Megan Allyse; Mary E Norton; Mildred K Cho
Journal:  Prenat Diagn       Date:  2011-07-27       Impact factor: 3.050

4.  Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy.

Authors:  Lauren C Sayres; Megan Allyse; Mildred K Cho
Journal:  Genome Med       Date:  2012-06-21       Impact factor: 11.117

5.  Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong.

Authors:  Huso Yi; Nina Hallowell; Sian Griffiths; Tak Yeung Leung
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.